DRKS00010872
Recruiting
Not Applicable
Prospective validation of the prognostic biomarker CD8+ TEMRA cells for disturbed fracture healing. - BioBone
Charité Universitätsmedizin Berlin / Berlin-Brandenburger Centrum für Regenerative Therapien / Julius Wolff Institut0 sites800 target enrollmentJuly 26, 2016
ConditionsS82.1S82.2S82.3S82.7S82.11S82.18S82.31S72S72.1S72.2S72.3S72.4S72.7S72.8Fracture of upper end of tibiaFracture of shaft of tibiaFracture of lower end of tibiaMultiple fractures of lower legFracture of femurPertrochanteric fractureSubtrochanteric fractureFracture of shaft of femurFracture of lower end of femurMultiple fractures of femurFractures of other parts of femur
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- S82.1
- Sponsor
- Charité Universitätsmedizin Berlin / Berlin-Brandenburger Centrum für Regenerative Therapien / Julius Wolff Institut
- Enrollment
- 800
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •full Age (18\+),
- •contractually capable,
- •patient who understand the informed consent \+ signed consent,
- •fracture of the Long bones,
- •surgery Treatment \= osteosynthesis,
- •patient was mobilised before the fracture/surgery occured
Exclusion Criteria
- •periprothetic fractures,
- •pathological fractures,
- •active Tumor disease,
- •active Tumor therapy/Treatment,
- •HIV, Hepatitis B and/or C positive,
- •drug\-dependent person
- •psyschological disease,
- •pregnant or nursing Person,
- •participation in another, parallel running interventional study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A study of evaluation to the predictive biomarker of Nivolumab in peripheral blood and pleural effusion.previously treated patients with advanced non-small-cell lung cancerJPRN-UMIN000023873Respiratory Medicine, Allergy and Rheu matic Diseases Osaka University Graduate School of Medicine10
Recruiting
Not Applicable
Validation of predictive and prognostic markers in upper gastrointestinal cancerpper gastrointestinal cancerJPRN-UMIN000030472Shimane University Faculty of Medicine800
Recruiting
Not Applicable
Prospective study to identify prognostic markers of pancreatic cancerpancreatic cancerJPRN-UMIN000034022Department of Gastroenterology and Hepatology, Kochi Medical School Hospital, Kochi University150
Recruiting
Not Applicable
A pilot study to investigate prognostic marker of degeneration from cervical intraepithelial neoplasia to cervix carcinomaC53N87C51N90C52N89Malignant neoplasm of cervix uteriDysplasia of cervix uteriMalignant neoplasm of vulvaOther noninflammatory disorders of vulva and perineumMalignant neoplasm of vaginaOther noninflammatory disorders of vaginaDRKS00024987Carl von Ossietzky Universität/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe550
Completed
Not Applicable
Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral researchJPRN-UMIN000042055Japan Agency for Medical Research and Development107